Sector revisions GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Delayed NSE India S.E. 06:31:39 19/08/2026 BST			5-day change	1st Jan Change
2,996.40 ^INR	+4.14%		+13.96%	+20.71%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							22
	ABBVIE INC.							29
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	AMGEN INC.							29
	NOVO NORDISK A/S							24
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	VERTEX PHARMACEUTICALS INCORPORATED							25
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							16
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							22
	Weighted average by Cap.							24